IL208239A0 - Highly bridged peptides from actinomadura namibiensis - Google Patents
Highly bridged peptides from actinomadura namibiensisInfo
- Publication number
- IL208239A0 IL208239A0 IL208239A IL20823910A IL208239A0 IL 208239 A0 IL208239 A0 IL 208239A0 IL 208239 A IL208239 A IL 208239A IL 20823910 A IL20823910 A IL 20823910A IL 208239 A0 IL208239 A0 IL 208239A0
- Authority
- IL
- Israel
- Prior art keywords
- bridged peptides
- actinomadura namibiensis
- highly bridged
- highly
- namibiensis
- Prior art date
Links
- 241001065356 Actinomadura namibiensis Species 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290324 | 2008-04-02 | ||
| PCT/EP2009/001982 WO2009121483A1 (en) | 2008-04-02 | 2009-03-18 | Highly bridged peptides from actinomadura namibiensis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL208239A0 true IL208239A0 (en) | 2010-12-30 |
Family
ID=39730602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL208239A IL208239A0 (en) | 2008-04-02 | 2010-09-19 | Highly bridged peptides from actinomadura namibiensis |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110144001A1 (de) |
| EP (1) | EP2271665B1 (de) |
| JP (1) | JP5653900B2 (de) |
| KR (1) | KR101612275B1 (de) |
| CN (1) | CN102046652B (de) |
| AR (1) | AR071125A1 (de) |
| AT (1) | ATE541856T1 (de) |
| AU (1) | AU2009231118B2 (de) |
| BR (1) | BRPI0910985A2 (de) |
| CA (1) | CA2720173A1 (de) |
| CL (1) | CL2009000791A1 (de) |
| IL (1) | IL208239A0 (de) |
| MX (1) | MX2010010115A (de) |
| MY (1) | MY159790A (de) |
| RU (1) | RU2498995C2 (de) |
| WO (1) | WO2009121483A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1908774A1 (de) * | 2006-10-06 | 2008-04-09 | sanofi-aventis | Antibakterielle und antivirale Peptide aus Actinomadura namibiensis |
| DK2257301T3 (da) | 2008-03-03 | 2014-04-28 | Univ Miami | Immunterapi baseret på allogene cancerceller. |
| KR20110017356A (ko) | 2008-03-20 | 2011-02-21 | 유니버시티 오브 마이애미 | 열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법 |
| EP2607374A1 (de) * | 2011-12-21 | 2013-06-26 | Sanofi | Verfahren zur rekombinanten Herstellung von Labyrinthopeptinen und funktionalen Derivaten davon |
| US10487124B2 (en) * | 2012-07-12 | 2019-11-26 | Naicons S.R.L. | Lantipeptide |
| US20190046604A1 (en) | 2015-11-18 | 2019-02-14 | Helmholtz-Zentrum für Infektionsforschung GmbH | Labyrinthopeptins as anti-viral agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0700998B1 (de) * | 1994-09-12 | 2003-11-26 | Aventis Pharma Deutschland GmbH | Rekombinantes Mersacidin und Verfahren zu seiner Herstellung |
| US5942423A (en) | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
| JP4664924B2 (ja) * | 2003-12-02 | 2011-04-06 | ウーツェーベー ファルマ ゲーエムベーハー | 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用 |
| CN100516218C (zh) * | 2006-04-30 | 2009-07-22 | 中山大学 | 一种新的线纹芋螺毒素序列、制备方法及其应用 |
| EP1908774A1 (de) * | 2006-10-06 | 2008-04-09 | sanofi-aventis | Antibakterielle und antivirale Peptide aus Actinomadura namibiensis |
| EP2607374A1 (de) * | 2011-12-21 | 2013-06-26 | Sanofi | Verfahren zur rekombinanten Herstellung von Labyrinthopeptinen und funktionalen Derivaten davon |
-
2009
- 2009-03-18 WO PCT/EP2009/001982 patent/WO2009121483A1/en not_active Ceased
- 2009-03-18 MY MYPI2010004183A patent/MY159790A/en unknown
- 2009-03-18 AU AU2009231118A patent/AU2009231118B2/en not_active Ceased
- 2009-03-18 EP EP09728150A patent/EP2271665B1/de not_active Not-in-force
- 2009-03-18 JP JP2011502252A patent/JP5653900B2/ja not_active Expired - Fee Related
- 2009-03-18 CN CN200980120478.5A patent/CN102046652B/zh not_active Expired - Fee Related
- 2009-03-18 RU RU2010144778/10A patent/RU2498995C2/ru not_active IP Right Cessation
- 2009-03-18 MX MX2010010115A patent/MX2010010115A/es active IP Right Grant
- 2009-03-18 AT AT09728150T patent/ATE541856T1/de active
- 2009-03-18 CA CA2720173A patent/CA2720173A1/en not_active Abandoned
- 2009-03-18 BR BRPI0910985A patent/BRPI0910985A2/pt not_active IP Right Cessation
- 2009-03-18 KR KR1020107022012A patent/KR101612275B1/ko not_active Expired - Fee Related
- 2009-03-31 AR ARP090101143A patent/AR071125A1/es unknown
- 2009-03-31 CL CL2009000791A patent/CL2009000791A1/es unknown
-
2010
- 2010-09-19 IL IL208239A patent/IL208239A0/en not_active IP Right Cessation
- 2010-09-30 US US12/895,106 patent/US20110144001A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010010115A (es) | 2010-09-30 |
| AR071125A1 (es) | 2010-05-26 |
| BRPI0910985A2 (pt) | 2019-09-24 |
| JP2011516048A (ja) | 2011-05-26 |
| RU2498995C2 (ru) | 2013-11-20 |
| US20110144001A1 (en) | 2011-06-16 |
| KR20110014563A (ko) | 2011-02-11 |
| ATE541856T1 (de) | 2012-02-15 |
| CA2720173A1 (en) | 2009-10-08 |
| KR101612275B1 (ko) | 2016-04-14 |
| EP2271665A1 (de) | 2011-01-12 |
| WO2009121483A1 (en) | 2009-10-08 |
| CN102046652A (zh) | 2011-05-04 |
| AU2009231118B2 (en) | 2013-06-27 |
| JP5653900B2 (ja) | 2015-01-14 |
| CL2009000791A1 (es) | 2009-10-09 |
| CN102046652B (zh) | 2014-11-05 |
| AU2009231118A1 (en) | 2009-10-08 |
| RU2010144778A (ru) | 2012-05-10 |
| MY159790A (en) | 2017-01-31 |
| EP2271665B1 (de) | 2012-01-18 |
| HK1155762A1 (en) | 2012-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0914110D0 (en) | Peptide libraries | |
| GB0723712D0 (en) | Peptides | |
| ZA201001451B (en) | Immunomodulatory peptides | |
| EP2017283A4 (de) | Peptide | |
| IL202120A0 (en) | Signaling peptides | |
| ZA201000283B (en) | Reinigung pegylierter polypeptide | |
| SI2125871T1 (sl) | Antibakterijski peptidi | |
| GB0920981D0 (en) | Peptides | |
| IL208239A0 (en) | Highly bridged peptides from actinomadura namibiensis | |
| EP2123666A4 (de) | Peptid | |
| ZA201108446B (en) | FViII-DERIVED PEPTIDES | |
| ZA201203722B (en) | Peptide | |
| GB0801513D0 (en) | Peptides from factor VIII | |
| GB0703945D0 (en) | Peptide | |
| EP2136831A4 (de) | Anti-angiogene peptide | |
| GB0920987D0 (en) | Peptides | |
| GB0618748D0 (en) | Peptide | |
| IL197675A0 (en) | Peptides | |
| GB0708529D0 (en) | Peptide standards | |
| GB0817978D0 (en) | Peptides | |
| GB0605774D0 (en) | Peptide | |
| GB0812586D0 (en) | Chimaeric peptide | |
| GB0705251D0 (en) | Peptides | |
| GB0707626D0 (en) | Peptides | |
| GB0705115D0 (en) | Peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |